Validation of a German version of the Validierung General attitude towards medication questionnaire (GAM-Q) in patients with prostate cnacer
- Conditions
- C61Malignant neoplasm of prostate
- Registration Number
- DRKS00022398
- Lead Sponsor
- Bereichs Schmerzmedizin und SchmerzpsychologieUniversitätsklinikum Hamburg-Eppendorf (UKE)?Zentrum für Anästhesiologie und Intensivmedizin?Klinik und Poliklinik für Anästhesiologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 108
Inclusion Criteria
prostatectomy
>=18 years of age
sufficient german language skills
patient can give consent (i.e. no dementia, that hinders consent)
Exclusion Criteria
severe acute or chronic psychiatric disease (i.e. acute psychotic episode)
cognitive impairment (i.e. impaired planing skills, impaired memory)
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The GAM-Q items will be evaluated. Inverted items will be changed accordingly. A principal component analysis will be conducted and subscales claculated. It will be tested wether the resulting subscales of items in this study correlates significantly with the results in other translations (Tekampe et. al. 2019). The data will be collected before the prostectomy via questionnaire.
- Secondary Outcome Measures
Name Time Method The secondary outcome is the convergent validity. The total score of the GAM-Q will be correlated with the total score of the BM-Q. This correlation will be tested for significant difference with the corrleation reported in the work of Tekampe et. al. 2019. The data will be collected before the prostectomy via questionnaire.